British American Tobacco (BAT) is one of the largest tobacco suppliers in the world. With the decline of the tobacco industry, they have doubled their investment in new product categories, such as electronic cigarettes.
The London-listed company's revenue has grown over the past few months, despite a growing trend towards smoking cessation in Europe and the United States.
The Covid-19 pandemic on both sides of the Atlantic has accelerated a shift away from smoking, and bosses of the world's biggest tobacco companies (BAT) now predict that global tobacco sales will remain at around 2% for the entire year.
The company stated that they had originally anticipated a further decline in sales, but the recovery of tobacco sales was triggered by the Covid-19 resurgence in emerging markets.
The company added that British American Tobacco's revenue growth for the second quarter is expected to be between 2% and 4%, as it did not disclose a specific number prior to the upcoming financial update.
The CEO, Jack Bowers, stated that the company will continue to invest in its new category as they seek to reduce operational losses.
We anticipate an increase in contributions from all new categories and regions in 2022. We are confident that we will achieve our goal of reaching 5 billion pounds in revenue and profits by 2025," stated the individual in a released statement.
In the United States, sales in the industry are still facing pressure due to ongoing macroeconomic factors and the post-Covid normalization of consumer behavior. To counter early signs of industry-wide price reductions in the second half of the year, we have recently launched a commercial plan that spans specific brands, channels, and states.
Although our supply chain inflation rate continues to rise, we anticipate a strong improvement in our adjusted operating profit margin. This will be achieved through robust pricing, the scale of our brand, and an increasingly focused marketing investment. By the end of 2022, our three-year Quantum program is expected to save over £1.5 billion in costs annually.
2FIRSTS will continue to report on this issue, and further updates will be available on the '2FIRSTS APP'. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
